Cargando…

Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?

The opioid receptors are a family of G-protein coupled receptors (GPCRs) with close structural homology. The opioid receptors are activated by a variety of endogenous opioid neuropeptides, principally β-endorphin, dynorphins, leu- and met-enkephalins. The clinical potential of targeting opioid recep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bailey, Sarah J., Husbands, Stephen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2018
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373229/ https://www.ncbi.nlm.nih.gov/pubmed/32714584 http://dx.doi.org/10.1042/NS20170145

Ejemplares similares

Stilbenes as κ-Selective, Non-nitrogenous Opioid Receptor Antagonists
por: Hartung, Alyssa M., et al.
Publicado: (2014)

Fumaroylamino-4,5-epoxymorphinans and Related Opioids with Irreversible μ Opioid Receptor Antagonist Effects
por: Moynihan, Humphrey A., et al.
Publicado: (2012)

Opioids in cancer: The κ-opioid receptor
por: Zhou, Qier, et al.
Publicado: (2022)

Selective κ Opioid Antagonists nor-BNI, GNTI and JDTic Have Low Affinities for Non-Opioid Receptors and Transporters
por: Munro, Thomas A., et al.
Publicado: (2013)

Major Depressive Disorder and Kappa Opioid Receptor Antagonists
por: Li, Wei, et al.
Publicado: (2016)

Ligand and G-protein selectivity in the κ-opioid receptor
por: Han, Jianming, et al.
Publicado: (2023)

Opioid Antagonists from the Orvinol Series as Potential Reversal Agents for Opioid Overdose
por: Disney, Alex, et al.
Publicado: (2022)

The novel μ‐opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception
por: Hill, Rob, et al.
Publicado: (2018)

Selectively Promiscuous Opioid Ligands: Discovery of High Affinity/Low Efficacy Opioid Ligands with Substantial Nociceptin Opioid Peptide Receptor Affinity
por: Kumar, Vinod, et al.
Publicado: (2014)

Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists
por: Park, Jong Yung, et al.
Publicado: (2019)

Development of a Selective Peptide κ-Opioid Receptor Antagonist by Late-Stage Functionalization with Cysteine Staples
por: Muratspahić, Edin, et al.
Publicado: (2023)

Negative modulation of spinal κ-opioid receptor-mediated antinociception by the µ-opioid receptor at selective doses of (−)-pentazocine
por: Robinson, Douglas L., et al.
Publicado: (2018)

Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist
por: Levy-Cooperman, N., et al.
Publicado: (2016)

C7β-Methyl Analogues of the Orvinols: The Discovery of Kappa Opioid Antagonists with Nociceptin/Orphanin FQ Peptide (NOP) Receptor Partial Agonism and Low, or Zero, Efficacy at Mu Opioid Receptors
por: Cueva, Juan Pablo, et al.
Publicado: (2015)

Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway
por: Miyano, Kanako, et al.
Publicado: (2021)

Plant-Derived Cyclotides Modulate κ-Opioid Receptor Signaling
por: Muratspahić, Edin, et al.
Publicado: (2021)

μ Opioid receptor: novel antagonists and structural modeling
por: Kaserer, Teresa, et al.
Publicado: (2016)

Peripherally acting opioid receptor antagonists in pediatric patients
por: Nair, Abhijit
Publicado: (2018)

Methylnaltrexone: Peripherally Acting µ-Opioid Receptor Antagonist
por: Uritsky, Tanya J.
Publicado: (2019)

Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats
por: Page, Sarah, et al.
Publicado: (2019)

Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation
por: Anantharamu, Tejus, et al.
Publicado: (2015)

Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
por: Peckham, Alyssa M., et al.
Publicado: (2018)

Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction?
por: Belltall, Amparo, et al.
Publicado: (2022)

De Novo Design of κ-Opioid Receptor Antagonists Using a Generative Deep-Learning Framework
por: Salas-Estrada, Leslie, et al.
Publicado: (2023)

Mu-opioid receptor selective superagonists produce prolonged respiratory depression
por: Malcolm, Nicholas J., et al.
Publicado: (2023)

Hyaluronic Acid Induces Activation of the κ-Opioid Receptor
por: Zavan, Barbara, et al.
Publicado: (2013)

In between Opioid Crisis and the Need to Treat Pain, where do we Stand?
por: Ionescu, Daniela, et al.
Publicado: (2022)

Structural insights into μ-opioid receptor activation
por: Huang, Weijiao, et al.
Publicado: (2015)

Pharmacologic Profile of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation
por: Floettmann, Eike, et al.
Publicado: (2017)

The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety
por: Pergolizzi Jr, Joseph V, et al.
Publicado: (2020)

Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
por: Tosh, Dilip K., et al.
Publicado: (2018)

Opioid Receptor-Mediated and Non-Opioid Receptor-Mediated Roles of Opioids in Tumour Growth and Metastasis
por: Scroope, Claudia A., et al.
Publicado: (2021)

Orvinols with Mixed Kappa/Mu Opioid Receptor Agonist Activity
por: Greedy, Benjamin M., et al.
Publicado: (2013)

Crystal structure of the μ-opioid receptor bound to a morphinan antagonist
por: Manglik, Aashish, et al.
Publicado: (2012)

Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?
por: Tabanelli, Rita, et al.
Publicado: (2023)

Discovery of the First Small-Molecule Opioid Pan Antagonist with Nanomolar Affinity at Mu, Delta, Kappa, and Nociceptin Opioid Receptors
por: Zaveri, Nurulain T., et al.
Publicado: (2015)

Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy
por: Pergolizzi, Joseph V, et al.
Publicado: (2017)

Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications
por: Streicher, John M., et al.
Publicado: (2017)

Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug Interactions
por: Gudin, Jeffrey, et al.
Publicado: (2020)

κ-opioid receptor is involved in the cardioprotection induced by exercise training
por: Geng, Xiao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a6eebrj5p9o43n50bommggb8jp